{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T05:26:10Z","timestamp":1708925170709},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.cyto.2014.05.020","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T09:02:27Z","timestamp":1402995747000},"page":"272-276","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in L\u00f6fgren\u2019s syndrome"],"prefix":"10.1016","volume":"69","author":[{"given":"B.","family":"Karakaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.H.M.","family":"van Moorsel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.H.M.","family":"van der Helm-van Mil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.W.J.","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.T.","family":"Ruven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"van der Vis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Grutters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2014.05.020_b0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.183.1.277","article-title":"An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction","volume":"183","author":"Bernhagen","year":"1996","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.cyto.2014.05.020_b0010","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","article-title":"The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor","volume":"179","author":"Calandra","year":"1994","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.cyto.2014.05.020_b0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nm0397-320","article-title":"Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome","volume":"3","author":"Donnelly","year":"1997","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.cyto.2014.05.020_b0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jdermsci.2004.08.007","article-title":"Role of macrophage migration inhibitory factor (MIF) in the skin","volume":"37","author":"Shimizu","year":"2005","journal-title":"J Dermatol Sci"},{"issue":"2","key":"10.1016\/j.cyto.2014.05.020_b0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/ajrccm.158.2.9707086","article-title":"Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation","volume":"158","author":"Makita","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"Supp. 1","key":"10.1016\/j.cyto.2014.05.020_b0030","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00003246-200201001-00004","article-title":"Macrophage migration inhibitory factor","volume":"30","author":"Baugh","year":"2002","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.cyto.2014.05.020_b0035","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"6544","key":"10.1016\/j.cyto.2014.05.020_b0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/377068a0","article-title":"MIF as a glucocorticoid-induced modulator of cytokine production","volume":"377","author":"Calandra","year":"1995","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cyto.2014.05.020_b0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S1357-4310(97)01133-7","article-title":"Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease","volume":"3","author":"Donnelly","year":"1997","journal-title":"Mol Med Today"},{"issue":"7","key":"10.1016\/j.cyto.2014.05.020_b0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.gene.6364014","article-title":"Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis","volume":"4","author":"Barton","year":"2003","journal-title":"Genes Immun"},{"issue":"9","key":"10.1016\/j.cyto.2014.05.020_b0055","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/art.10492","article-title":"Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis","volume":"46","author":"Donn","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.cyto.2014.05.020_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0090-1229(79)90018-7","article-title":"Serum-migration inhibitory activity in patients with sarcoidosis","volume":"13","author":"Yoshida","year":"1979","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.cyto.2014.05.020_b0065","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1529-0131(200201)46:1<232::AID-ART10059>3.0.CO;2-B","article-title":"Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis","volume":"46","author":"Meazza","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"40","key":"10.1016\/j.cyto.2014.05.020_b0070","doi-asserted-by":"crossref","first-page":"14410","DOI":"10.1073\/pnas.0507189102","article-title":"Role for macrophage migration inhibitory factor in asthma","volume":"102","author":"Mizue","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.cyto.2014.05.020_b0075","doi-asserted-by":"crossref","first-page":"e33752","DOI":"10.1371\/journal.pone.0033752","article-title":"PTRF\/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics","volume":"7","author":"Gamez-Pozo","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.cyto.2014.05.020_b0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.resp.2009.05.004","article-title":"Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis","volume":"167","author":"Bargagli","year":"2009","journal-title":"Respir Physiol Neurobiol"},{"issue":"11","key":"10.1016\/j.cyto.2014.05.020_b0085","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/rheumatology\/ker259","article-title":"Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population","volume":"50","author":"Bossini-Castillo","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.cyto.2014.05.020_b0090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.gene.6364310","article-title":"Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus","volume":"7","author":"Sanchez","year":"2006","journal-title":"Genes Immun"},{"issue":"8","key":"10.1016\/j.cyto.2014.05.020_b0095","first-page":"1671","article-title":"Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum","volume":"29","author":"Amoli","year":"2002","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.cyto.2014.05.020_b0100","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"Statement on sarcoidosis","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cyto.2014.05.020_b0105","first-page":"1","article-title":"Erythema nodosum: studies on etiology and pathogenesisin 185 adult cases","volume":"124","author":"L\u00f6fgren","year":"1946","journal-title":"Acta Med Scand"},{"issue":"6","key":"10.1016\/j.cyto.2014.05.020_b0110","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0002-9343(74)90160-0","article-title":"Course and prognosis of sarcoidosis around the world","volume":"57","author":"Siltzbach","year":"1974","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.cyto.2014.05.020_b0115","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1164\/ajrccm.165.8.200110-0320","article-title":"Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis","volume":"165","author":"Grutters","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.cyto.2014.05.020_b0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-0039.2005.00370.x","article-title":"Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren\u2019s syndrome in Czech patients with sarcoidosis","volume":"65","author":"Mrazek","year":"2005","journal-title":"Tissue Antigens"},{"issue":"2\u20133","key":"10.1016\/j.cyto.2014.05.020_b0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.imlet.2003.11.005","article-title":"Combined association between IFN-gamma 3,3 homozygosity and DRB1\u221703 in Lofgren\u2019s syndrome patients","volume":"91","author":"Wysoczanska","year":"2004","journal-title":"Immunol Lett"},{"issue":"4","key":"10.1016\/j.cyto.2014.05.020_b0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.200807-1082OC","article-title":"Lofgren\u2019s syndrome: human leukocyte antigen strongly influences the disease course","volume":"179","author":"Grunewald","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.cyto.2014.05.020_b0135","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/art.20178","article-title":"A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis","volume":"50","author":"Donn","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.cyto.2014.05.020_b0140","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1749-6632.1970.tb55994.x","article-title":"Relation of the migration inhibitory factor (MIF) to delayed-type hypersensitivity reactions","volume":"169","author":"Bloom","year":"1970","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.cyto.2014.05.020_b0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1073\/pnas.56.1.72","article-title":"Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction","volume":"56","author":"David","year":"1966","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"10.1016\/j.cyto.2014.05.020_b0150","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1073\/pnas.93.15.7849","article-title":"An essential regulatory role for macrophage migration inhibitory factor in T-cell activation","volume":"93","author":"Bacher","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.cyto.2014.05.020_b0155","first-page":"417","article-title":"In vitro production of inhibitors of monocyte locomotion by the granuloma of sarcoidosis","volume":"130","author":"Campbell","year":"1984","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.cyto.2014.05.020_b0160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2249.2008.03832.x","article-title":"Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis","volume":"155","author":"Arakelyan","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2014.05.020_b0165","doi-asserted-by":"crossref","unstructured":"Requena L, Yus ES. Erythema nodosum. Dermatol Clin 2008;26(4):425,38, v.","DOI":"10.1016\/j.det.2008.05.014"},{"issue":"5","key":"10.1016\/j.cyto.2014.05.020_b0170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00011-012-0447-5","article-title":"The association between the functional PTPN22 1858 C\/T and MIF -173 C\/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis","volume":"61","author":"Lee","year":"2012","journal-title":"Inflamm Res"},{"issue":"9","key":"10.1016\/j.cyto.2014.05.020_b0175","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.humimm.2012.07.043","article-title":"Association of MIF- 173G\/C and MBL2 codon 54 gene polymorphisms with rheumatoid arthritis: a meta-analysis","volume":"73","author":"Xie","year":"2012","journal-title":"Hum Immunol"},{"issue":"21","key":"10.1016\/j.cyto.2014.05.020_b0180","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.cyto.2014.05.020_b0185","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/jmedgenet-2013-101532","article-title":"Recent advances in the genetics of sarcoidosis","volume":"50","author":"Spagnolo","year":"2013","journal-title":"J Med Genet"},{"issue":"5","key":"10.1016\/j.cyto.2014.05.020_b0190","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1399-0004.2008.00970.x","article-title":"Advances in the genetics of sarcoidosis","volume":"73","author":"Smith","year":"2008","journal-title":"Clin Genet"},{"issue":"5","key":"10.1016\/j.cyto.2014.05.020_b0195","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MCP.0b013e3283043de7","article-title":"Genetics of sarcoidosis","volume":"14","author":"Grunewald","year":"2008","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.cyto.2014.05.020_b0200","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/rheumatology\/ken005","article-title":"Recent advances in the genetics of RA susceptibility","volume":"47","author":"Bowes","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.cyto.2014.05.020_b0205","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.arcmed.2011.05.004","article-title":"Genetic susceptibility to juvenile idiopathic arthritis in Iranian children","volume":"42","author":"Farivar","year":"2011","journal-title":"Arch Med Res"},{"issue":"6","key":"10.1016\/j.cyto.2014.05.020_b0210","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/art.27424","article-title":"Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects","volume":"62","author":"Hollenbach","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"20","key":"10.1016\/j.cyto.2014.05.020_b0215","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/hmg\/ddq325","article-title":"Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups","volume":"19","author":"Sato","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.cyto.2014.05.020_b0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJM200007063430107","article-title":"The immune system","volume":"343","author":"Delves","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cyto.2014.05.020_b0225","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1056\/NEJM200007133430207","article-title":"The immune system","volume":"343","author":"Delves","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.cyto.2014.05.020_b0230","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.cyto.2014.05.020_b0235","first-page":"576","article-title":"Lack of association between macrophage migration inhibitory factor gene (-173 G\/C) polymorphism and cutaneous vasculitis","volume":"24","author":"Amoli","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.cyto.2014.05.020_b0240","first-page":"74","article-title":"Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis","volume":"32","author":"Amoli","year":"2005","journal-title":"J Rheumatol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614001537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614001537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T12:08:50Z","timestamp":1565525330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466614001537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1043466614001537"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2014.05.020","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in L\u00f6fgren\u2019s syndrome","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2014.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}